TEST BANK mn
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
mn mn mn mn mn mn mn
Author: Teri Moser Woo and Wendy L. Wright
mn mn mn mn mn mn mn
, TABLE OF CONTENT mn mn
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber...................................................................... 4
mn mn mn mn mn mn mn mn mn mn
Chapter 2. Review of Basic Principles of Pharmacology ..................................................................................... 5
mn mn mn mn mn mn mn
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
mn mn mn mn
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
mn mn mn mn mn mn mn
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
mn mn mn mn
Chapter 6. An Introduction to Pharmacogenomics.............................................................................................. 19
mn mn mn mn mn
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
mn mn mn mn
Chapter 8. Herbal Therapies ................................................................................................................................ 28
mn mn mn
Chapter 9. Cannabis ............................................................................................................................................ 31
mn mn
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
mn mn
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
mn mn mn mn mn mn mn
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
mn mn mn mn mn mn mn
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
mn mn mn mn mn mn mn mn
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
mn mn mn mn mn mn
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
mn mn mn mn mn mn
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
mn mn mn mn mn mn mn mn mn
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
mn mn mn mn mn mn mn
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
mn mn mn mn mn mn
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .................... 80
mn mn mn mn mn mn mn mn mn mn mn
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
mn mn mn mn mn mn mn mn mn mn mn
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
mn mn mn mn mn mn
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
mn mn mn mn mn mn mn
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
mn mn mn mn mn mn
Chapter 24. Drugs Used to Treat Bacterial Infections....................................................................................... 101
mn mn mn mn mn mn mn
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections........................................................ 105
mn mn mn mn mn mn mn mn mn mn
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
mn mn mn mn mn mn mn
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
mn mn mn mn mn mn mn mn mn
Chapter 28. Anemia........................................................................................................................................... 113
mn mn
Chapter 29. Anxiety and Depression................................................................................................................. 116
mn mn mn mn
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
mn mn mn mn
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
mn mn mn mn
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
mn mn mn mn mn
Chapter 33. Contraception ................................................................................................................................. 127
mn mn
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
mn mn mn mn mn
Chapter 35. Dermatological Conditions ............................................................................................................ 134
mn mn mn
Chapter 36. Diabetes Management ................................................................................................................... 138
mn mn mn
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
mn mn mn mn mn mn mn
Chapter 38. Headaches ...................................................................................................................................... 149
mn mn
Chapter 39. Heart Failure .................................................................................................................................. 153
mn mn mn
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
mn mn mn mn mn mn mn
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
mn mn mn mn
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
mn mn
Chapter 43. Hypertension .................................................................................................................................. 169
mn mn
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
mn mn mn mn
Chapter 45. Obesity ........................................................................................................................................... 177
mn mn
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
mn mn mn mn mn mn mn
Chapter 47. Pneumonia ..................................................................................................................................... 185
mn mn
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
mn mn mn mn mn mn
Chapter 49. Substance Use Disorders ............................................................................................................... 190
mn mn mn mn
Chapter 50. Tuberculosis ................................................................................................................................... 195
mn mn
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ........... 197
mn mn mn mn mn mn mn mn mn mn mn mn
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
mn mn mn mn
Chapter 53. Women as Patients......................................................................................................................... 203
mn mn mn mn
Chapter 54. Men as Patients .............................................................................................................................. 207
mn mn mn mn
Chapter 55. Pediatric Patients............................................................................................................................ 209
mn mn mn
Chapter 57. Geriatric Patients............................................................................................................................ 213
mn mn mn
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e mn mn mn mn Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
mn mn mn mn mn mn mn mn mn mn
MULTIPLE CHOICE mn
1. Nurse practitioner prescriptive authority is regulated by:
mn mn mn mn mn mn
A. The National Council of State Boards of Nursing
mn mn mn mn mn mn mn
B. The U.S. Drug Enforcement Administration
mn mn mn mn
C. The State Board of Nursing for each state
mn mn mn mn mn mn mn
D. The State Board of Pharmacymn mn mn mn
ANS: m n C PTS: m n m n 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
mn mn mn mn mn mn mn mn mn mn mn mn mn
include:
mn
A. Nurses know more about pharmacology than other prescribers because they take it
mn mn mn mn mn mn mn mn mn mn mn
both in their basic nursing program and in their APRN program.
mn mn mn mn mn mn mn mn mn mn mn
B. Nurses care for the patient from a holistic approach and include the patient in
mn mn mn mn mn mn mn mn mn mn mn mn mn
decision-making regarding their care.
mn mn mn mn
C. APRNs are less likely to prescribe narcotics and other controlled substances.
mn mn mn mn mn mn mn mn mn mn
D. APRNs are able to prescribe independently in all states, whereas a physician’s
mn mn mn mn mn mn mn mn mn mn mn
assistant needs to have a physician supervising their practice.
mn mn mn mn mn mn mn mn mn
ANS: m n B PTS: m n m n 1
3. Clinical judgment in prescribing includes:
mn mn mn mn
A. Factoring in the cost to the patient of the medication prescribed
mn mn mn mn mn mn mn mn mn mn
B. Always prescribing the newest medication available for the disease process
mn mn mn mn mn mn mn mn mn
C. Handing out drug samples to poor patients mn mn mn mn mn mn
D. Prescribing all generic medications to cut costs mn mn mn mn mn mn
ANS: m n A PTS: m n m n 1
4. The process for choosing an effective drug for a disorder includes:
mn mn mn mn mn mn mn mn mn mn
A. Asking the patient what drug they think would work best for them
mn mn mn mn mn mn mn mn mn mn mn
B. Consulting nationally recognized guidelines for disease management mn mn mn mn mn mn
C. Prescribing medications that are available as samples before writing a prescription
mn mn mn mn mn mn mn mn mn mn
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
mn mn mn mn mn mn mn
ANS: m n B PTS: m n m n 1
5. Nonintentional nonadherence of drug therapy may occur due to: mn mn mn mn mn mn mn mn
A. Belief that medication does not work mn mn mn mn mn
B. Adverse drug reactions mn mn
C. Chronic conditions that require daily therapy mn mn mn mn mn
D. Forgetfulness or distraction mn mn
ANS: m n D PTS: m n m n 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
mn mn mn mn mn mn mn
Author: Teri Moser Woo and Wendy L. Wright
mn mn mn mn mn mn mn
, TABLE OF CONTENT mn mn
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber...................................................................... 4
mn mn mn mn mn mn mn mn mn mn
Chapter 2. Review of Basic Principles of Pharmacology ..................................................................................... 5
mn mn mn mn mn mn mn
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
mn mn mn mn
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
mn mn mn mn mn mn mn
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
mn mn mn mn
Chapter 6. An Introduction to Pharmacogenomics.............................................................................................. 19
mn mn mn mn mn
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
mn mn mn mn
Chapter 8. Herbal Therapies ................................................................................................................................ 28
mn mn mn
Chapter 9. Cannabis ............................................................................................................................................ 31
mn mn
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
mn mn
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
mn mn mn mn mn mn mn
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
mn mn mn mn mn mn mn
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
mn mn mn mn mn mn mn mn
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
mn mn mn mn mn mn
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
mn mn mn mn mn mn
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
mn mn mn mn mn mn mn mn mn
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
mn mn mn mn mn mn mn
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
mn mn mn mn mn mn
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .................... 80
mn mn mn mn mn mn mn mn mn mn mn
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
mn mn mn mn mn mn mn mn mn mn mn
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
mn mn mn mn mn mn
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
mn mn mn mn mn mn mn
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
mn mn mn mn mn mn
Chapter 24. Drugs Used to Treat Bacterial Infections....................................................................................... 101
mn mn mn mn mn mn mn
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections........................................................ 105
mn mn mn mn mn mn mn mn mn mn
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
mn mn mn mn mn mn mn
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
mn mn mn mn mn mn mn mn mn
Chapter 28. Anemia........................................................................................................................................... 113
mn mn
Chapter 29. Anxiety and Depression................................................................................................................. 116
mn mn mn mn
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
mn mn mn mn
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
mn mn mn mn
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
mn mn mn mn mn
Chapter 33. Contraception ................................................................................................................................. 127
mn mn
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
mn mn mn mn mn
Chapter 35. Dermatological Conditions ............................................................................................................ 134
mn mn mn
Chapter 36. Diabetes Management ................................................................................................................... 138
mn mn mn
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
mn mn mn mn mn mn mn
Chapter 38. Headaches ...................................................................................................................................... 149
mn mn
Chapter 39. Heart Failure .................................................................................................................................. 153
mn mn mn
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
mn mn mn mn mn mn mn
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
mn mn mn mn
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
mn mn
Chapter 43. Hypertension .................................................................................................................................. 169
mn mn
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
mn mn mn mn
Chapter 45. Obesity ........................................................................................................................................... 177
mn mn
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
mn mn mn mn mn mn mn
Chapter 47. Pneumonia ..................................................................................................................................... 185
mn mn
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
mn mn mn mn mn mn
Chapter 49. Substance Use Disorders ............................................................................................................... 190
mn mn mn mn
Chapter 50. Tuberculosis ................................................................................................................................... 195
mn mn
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ........... 197
mn mn mn mn mn mn mn mn mn mn mn mn
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
mn mn mn mn
Chapter 53. Women as Patients......................................................................................................................... 203
mn mn mn mn
Chapter 54. Men as Patients .............................................................................................................................. 207
mn mn mn mn
Chapter 55. Pediatric Patients............................................................................................................................ 209
mn mn mn
Chapter 57. Geriatric Patients............................................................................................................................ 213
mn mn mn
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e mn mn mn mn Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
mn mn mn mn mn mn mn mn mn mn
MULTIPLE CHOICE mn
1. Nurse practitioner prescriptive authority is regulated by:
mn mn mn mn mn mn
A. The National Council of State Boards of Nursing
mn mn mn mn mn mn mn
B. The U.S. Drug Enforcement Administration
mn mn mn mn
C. The State Board of Nursing for each state
mn mn mn mn mn mn mn
D. The State Board of Pharmacymn mn mn mn
ANS: m n C PTS: m n m n 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
mn mn mn mn mn mn mn mn mn mn mn mn mn
include:
mn
A. Nurses know more about pharmacology than other prescribers because they take it
mn mn mn mn mn mn mn mn mn mn mn
both in their basic nursing program and in their APRN program.
mn mn mn mn mn mn mn mn mn mn mn
B. Nurses care for the patient from a holistic approach and include the patient in
mn mn mn mn mn mn mn mn mn mn mn mn mn
decision-making regarding their care.
mn mn mn mn
C. APRNs are less likely to prescribe narcotics and other controlled substances.
mn mn mn mn mn mn mn mn mn mn
D. APRNs are able to prescribe independently in all states, whereas a physician’s
mn mn mn mn mn mn mn mn mn mn mn
assistant needs to have a physician supervising their practice.
mn mn mn mn mn mn mn mn mn
ANS: m n B PTS: m n m n 1
3. Clinical judgment in prescribing includes:
mn mn mn mn
A. Factoring in the cost to the patient of the medication prescribed
mn mn mn mn mn mn mn mn mn mn
B. Always prescribing the newest medication available for the disease process
mn mn mn mn mn mn mn mn mn
C. Handing out drug samples to poor patients mn mn mn mn mn mn
D. Prescribing all generic medications to cut costs mn mn mn mn mn mn
ANS: m n A PTS: m n m n 1
4. The process for choosing an effective drug for a disorder includes:
mn mn mn mn mn mn mn mn mn mn
A. Asking the patient what drug they think would work best for them
mn mn mn mn mn mn mn mn mn mn mn
B. Consulting nationally recognized guidelines for disease management mn mn mn mn mn mn
C. Prescribing medications that are available as samples before writing a prescription
mn mn mn mn mn mn mn mn mn mn
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
mn mn mn mn mn mn mn
ANS: m n B PTS: m n m n 1
5. Nonintentional nonadherence of drug therapy may occur due to: mn mn mn mn mn mn mn mn
A. Belief that medication does not work mn mn mn mn mn
B. Adverse drug reactions mn mn
C. Chronic conditions that require daily therapy mn mn mn mn mn
D. Forgetfulness or distraction mn mn
ANS: m n D PTS: m n m n 1
